maltodextrin
Small moleculeexperimental
Maltodextrin is a name shared by two different families of chemicals. Both families are glucose polymers, but have little chemical or nutritional similarity. — Wikipedia
Clinical trial activity
311 trials · 319 clinical orgs · 0 marketing orgs
Phase 1
18
Phase 2
47
Phase 3
22
Phase 4
6
Earliest trial started Jan 1, 2003 (NCT00955500)
Timeline
Indications
Approved for
Studied for
- Adenocarcinoma · Phase 1/Phase 2
- Alcohol-Induced Disorders · Phase 2
- Alzheimer Disease · Phase 3
- Anemia, Sickle Cell · Phase 3
- Anxiety · Phase 2
- Arthralgia · Phase 3
- Arthroplasty, Replacement, Knee · Early Phase 1
- beta-Thalassemia · Phase 3
- Binge Drinking · Phase 2
- Bone Diseases · Phase 1
- Bone Diseases, Endocrine · Early Phase 1
- Carbohydrates · Early Phase 1
- Carcinoma, Hepatocellular · Phase 2
- Cardiovascular Diseases · Phase 2
- Central Serous Chorioretinopathy · Phase 2/Phase 3
- Circulatory and Respiratory Physiological Phenomena · Phase 3
- Colitis, Ulcerative · Early Phase 1
- Constipation · Phase 4
- COVID-19 · Phase 2/Phase 3
- Critical Illness · Phase 3
- Crohn Disease · Early Phase 1
- Dermatitis, Atopic · Phase 3
- Diabetes Mellitus, Type 1 · Phase 1
- Diarrhea · Phase 2
- Diet Therapy · Phase 2
- Drug-Related Side Effects and Adverse Reactions · Phase 2
- Dyspepsia · Phase 1/Phase 2
- Eczema · Phase 2
- Endothelial Cells · Phase 2
- Enteral Nutrition · Phase 3
- Enteritis · Phase 3
- Exercise · Phase 3
- Fatigue · Phase 2
- Fibrosis · Phase 2
- Gastrointestinal Microbiome · Phase 2
- General Surgery · Phase 3
- Geriatrics · Early Phase 1
- Healthy Volunteers · Phase 4
- Heart Failure · Phase 1
- Hepatic Encephalopathy · Phase 4
- Hypersensitivity · Phase 2
- Infections · Phase 3
- Inflammation · Phase 4
- Insulin Resistance · Phase 3
- Intensive Care Units · Phase 2
- Intestinal Neoplasms · Phase 3
- Irritable Bowel Syndrome · Phase 3
- Kidney Diseases · Phase 2
- Kidney Failure, Chronic · Phase 4
- Liver Failure · Phase 2
- Major Depressive Disorder · Phase 2
- Mental Health · Phase 4
- Metabolic Syndrome · Phase 2
- Mitochondrial Diseases · Phase 2
- Mobility Limitation · Phase 3
- Mucositis · Phase 2
- Multiple Organ Failure · Phase 3
- Multiple Sclerosis · Phase 2
- Muscle Fatigue · Phase 3
- Myalgia · Phase 3
- Neonatal Sepsis · Phase 3
- Non-alcoholic Fatty Liver Disease · Phase 2
- Nutritional and Metabolic Diseases · Early Phase 1
- Obesity · Phase 2
- Osteoarthritis, Knee · Phase 2
- Overweight · Phase 2
- Pain · Phase 2
- Parkinson Disease · Phase 2
- Pediatric Obesity · Phase 3
- Polycystic Ovary Syndrome · Phase 2
- Postoperative Complications · Early Phase 1
- Pouchitis · Phase 1
- Prediabetic State · Phase 1
- Proctitis · Phase 3
- Prostatic Neoplasms · Phase 2/Phase 3
- Quality of Life · Phase 1
- Renal Insufficiency, Chronic · Phase 2
- Respiratory Aspiration · Phase 2
- Rotator Cuff · Early Phase 1
- Sarcopenia · Phase 2
- SARS-CoV-2 · Phase 2
- Sepsis · Phase 2
- Signs and Symptoms, Digestive · Phase 1/Phase 2
- Steatitis · Phase 1
- Stomach Neoplasms · Phase 3
- Stomatitis · Phase 2
- Stress Disorders, Post-Traumatic · Phase 2
- Typhoid Fever · Early Phase 1
- Vaccines · Early Phase 1
- Ventricular Dysfunction, Left · Phase 4
- Ventricular Dysfunction, Right · Phase 4
- Vitamin D Deficiency · Early Phase 1
- Vocal Cord Dysfunction · Phase 4
Mechanism of action
- microRNA 21Supplementation
microRNA 21 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMaltodextrin ↗
- NCATS7CVR7L4A2D ↗
- ChEMBLCHEMBL2107951 ↗
Also known as
- maltodextrin
- maltodextrin
- maltodextrin
- maltodextrin
- maltodextrins
- resistant maltodextrin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07189585 | Phase 2 | Apr 1, 2026 | Department of Veteran Affairs, National Center for Complementary and Integrative Health (NCCIH), Yale University |
| NCT07296692 | N/A | Jan 31, 2026 | Federal University of Minas Gerais, Nestle |
| NCT07276009 | N/A | Dec 1, 2025 | Nordic Bioscience |
| NCT07263217 | N/A | Oct 1, 2025 | Zhejiang University |
| NCT07201909 | N/A | Sep 22, 2025 | Myota GmbH, University of Reading |
| NCT07190989 | N/A | Sep 21, 2025 | Aspire Academy |
| NCT07062198 | Phase 3 | Sep 12, 2025 | ScandiBio Therapeutics AB |
| NCT06873204 | N/A | Jul 31, 2025 | Purdue University |
| NCT07013409 | N/A | Jul 1, 2025 | Wecare Probiotics Co., Ltd. |
| NCT06852365 | Phase 2 | Jun 10, 2025 | National Heart, Lung, and Blood Institute (NHLBI), University of Pennsylvania |
| NCT06987279 | N/A | Jun 10, 2025 | Wecare Probiotics Co., Ltd. |
| NCT07271576 | N/A | Jun 4, 2025 | Zhejiang University |
| NCT06836024 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2025 | Hamilton Health Sciences Corporation |
| NCT06920667 | N/A | Jun 1, 2025 | National Autonomous University of Mexico, University of Illinois at Chicago |
| NCT06956131 | N/A | May 29, 2025 | National University of Singapore |
| NCT06993428 | Phase 2 | May 20, 2025 | Clinical Trial Consultants AB, Empros Pharma AB |
| NCT07020754 | Phase 2 | Apr 1, 2025 | Ain Shams University |
| NCT06937190 | N/A | Apr 1, 2025 | Ankara Yildirim Beyazıt University |
| NCT06853912 | Phase 2 | Mar 1, 2025 | University of Washington |
| NCT06728098 | N/A | Feb 25, 2025 | Wecare Probiotics Co., Ltd. |
Showing 20 of 311 trials
Page 1 / 16
Organizations
Research & Development (319)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Maastricht University | Academic/Hospital | 8 | 7 | 2 | 2014 |
| University of Reading | Academic/Hospital | 8 | 6 | 1 | 2012 |
| Wecare Probiotics Co., Ltd. | For profit | 8 | 8 | 1 | 2024 |
| University of Nottingham | Academic/Hospital | 7 | 7 | 1 | 2018 |
| Aarhus University | Academic/Hospital | 6 | 6 | 3 | 2016 |
| Nestle | For profit | 6 | 5 | 1 | 2011 |
| Federal University of Minas Gerais | Academic/Hospital | 5 | 5 | 1 | 2014 |
| Shahid Beheshti University of Medical Sciences | Academic/Hospital | 5 | 3 | 2 | 2016 |
| University of Alberta | Academic/Hospital | 5 | 5 | 2 | 2012 |
| University of London | Academic/Hospital | 5 | 4 | 2 | 2010 |
| Biofortis | For profit | 4 | 1 | 1 | 2015 |
| FrieslandCampina | For profit | 4 | 1 | 1 | 2018 |
| Purdue University | Academic/Hospital | 4 | 4 | 1 | 2015 |
| RDC Clinical Pty Ltd | For profit | 4 | 4 | 1 | 2023 |
| Zhejiang University | Academic/Hospital | 4 | 4 | 1 | 2020 |
| Aristotle University of Thessaloniki | Academic/Hospital | 3 | 3 | 1 | 2021 |
| Beneo GmbH | For profit | 3 | 0 | 1 | 2018 |
| Cargill | For profit | 3 | 0 | 1 | 2018 |
| Cayetano Heredia University | Academic/Hospital | 3 | 3 | 2 | 2010 |
| Children's Memorial Health Institute, Poland | Academic/Hospital | 3 | 3 | 1 | 2012 |
319 organizations
Page 1 / 16